Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
Jøntvedt Jørgensen, Marthe, Nore, Kristin G., Aass, Hans Christian D., Layre, Emilie, Nigou, Jérôme, Mortensen, Rasmus, Tasken, Kjetil, Kvale, Dag, Jenum, Synne, Tonby, Kristian, Dyrhol-Riise, Anne Ma
Published in Frontiers in cellular and infection microbiology (09.07.2021)
Published in Frontiers in cellular and infection microbiology (09.07.2021)
Get full text
Journal Article
The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth
Nore, Kristin G, Louet, Claire, Bugge, Marit, Gidon, Alexandre, Jørgensen, Marthe Jøntvedt, Jenum, Synne, Dyrhol-Riise, Anne Ma, Tonby, Kristian, Flo, Trude Helen
Published in The Journal of infectious diseases (14.03.2024)
Published in The Journal of infectious diseases (14.03.2024)
Get full text
Journal Article